Skip to main content
. Author manuscript; available in PMC: 2012 Jun 11.
Published in final edited form as: Antioxid Redox Signal. 2011 May 11;15(4):1085–1127. doi: 10.1089/ars.2010.3663

FIG. 14.

FIG. 14

AsIII drugs. ATO is approved for treatment of acute promyelocytic leukemia, whereas the other compounds are in (pre)clinical development.